Erin E. Mulkearns-Hubert

4.0k citations

26 papers · 2.3k indexed · 1 hit paper · h-index 18

Molecular Biology top 10%
Oncology top 5%
Genetics top 1%
Cancer Research top 5%
Immunology top 10%

Co-authors: Justin D. Lathia Jeremy N. Rich Stephen C. Mack Claudia L.L. Valentim Ofer Reizes Maksim Sinyuk Alvaro G. Alvarado James S. Hale
Topics: Connexins and lens biology (8 papers)Cancer Cells and Metastasis (7 papers)Glioma Diagnosis and Treatment (6 papers)
Cited by: Genetics Cancer Research Oncology
Journals: Genes & Development Cancer Research Clinical Cancer Research
Partner nations: United States Denmark Finland

In The Last Decade

Erin E. Mulkearns-Hubert

25 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer stem cells in glioblastoma

2015 1.2k citations Justin D. Lathia, Stephen C. Mack et al. Genes & Development profile →

Peers

Countries citing papers authored by Erin E. Mulkearns-Hubert

Since Specialization

Citations

This map shows the geographic impact of Erin E. Mulkearns-Hubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin E. Mulkearns-Hubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin E. Mulkearns-Hubert more than expected).

Fields of papers citing papers by Erin E. Mulkearns-Hubert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin E. Mulkearns-Hubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin E. Mulkearns-Hubert. The network helps show where Erin E. Mulkearns-Hubert may publish in the future.

Co-authorship network of co-authors of Erin E. Mulkearns-Hubert

This figure shows the co-authorship network connecting the top 25 collaborators of Erin E. Mulkearns-Hubert. A scholar is included among the top collaborators of Erin E. Mulkearns-Hubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin E. Mulkearns-Hubert. Erin E. Mulkearns-Hubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Connexin 43 drives glioblastoma cancer stem cell phenotypes through a WNK lysine-deficient protein kinase 1-c-MYC signaling axis 2025 ·Cell Reports ·Erin E. Mulkearns-Hubert,(unknown),Ellen S. Hong,(unknown),(unknown),(unknown),(unknown),Kristen Kay,Sabrina Wang,Peter S. LaViolette,Daniel J. Silver,Christopher G. Hubert,Andrew Dhawan,Justin D. Lathia	1
2	miR-644a is a tumor cell-intrinsic mediator of sex bias in glioblastoma 2024 ·Neuro-Oncology Advances ·Ellen S. Hong,Sabrina Wang,(unknown),(unknown),Juyeun Lee,Erin E. Mulkearns-Hubert,(unknown),Kristen Kay,Justin D. Lathia,Andrew Dhawan	0
3	Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer 2023 ·Molecular Cancer Therapeutics ·Erin E. Mulkearns-Hubert,(unknown),Salma Ben‐Salem,Rashmi Bharti,(unknown),Sadie Johnson,(unknown),(unknown),Smarajit Bandyopadhyay,Charis Eng,(unknown),Justin D. Lathia,Ofer Reizes	6
4	Homeostatic iron regulatory protein drives glioblastoma growth via tumor cell-intrinsic and sex-specific responses 2023 ·Neuro-Oncology Advances ·Katie Troike,Sabrina Wang,Daniel J. Silver,Juyeun Lee,Erin E. Mulkearns-Hubert,(unknown),(unknown),Kristen Kay,(unknown),(unknown),Christopher W. Bishop,Ellen S. Hong,Mykyta Artomov,Christopher G. Hubert,Prajwal Rajappa,James R. Connor,Paul L. Fox,Bjarne Winther Kristensen,Justin D. Lathia	1
5	SerpinB3 drives cancer stem cell survival in glioblastoma 2022 ·Cell Reports ·(unknown),(unknown),Soumya M. Turaga,Defne Bayık,Daniel J. Silver,Kelly Mitchell,Erin E. Mulkearns-Hubert,Dionysios C. Watson,(unknown),(unknown),Hao Jing,Kathleen McCortney,Alicia Steffens,Ulhas P. Naik,Manmeet S. Ahluwalia,Shideng Bao,Craig Horbinski,Jennifer S. Yu,Justin D. Lathia	21
6	Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome 2021 ·Clinical Cancer Research ·Balint Otvos,Tyler Alban,Matthew M. Grabowski,Defne Bayık,Erin E. Mulkearns-Hubert,Tomas Radivoyevitch,(unknown),Sadie Johnson,(unknown),Alireza M. Mohammadi,Gene H. Barnett,Manmeet S. Ahluwalia,Michael A. Vogelbaum,Peter E. Fecci,Justin D. Lathia	23
7	Development of a Cx46 Targeting Strategy for Cancer Stem Cells 2019 ·Cell Reports ·Erin E. Mulkearns-Hubert,Luke A. Torre-Healy,Daniel J. Silver,(unknown),Defne Bayık,(unknown),Masahiro Hitomi,John Zhou,Bartlomiej Przychodzen,Renliang Zhang,Samuel A. Sprowls,James S. Hale,Tyler Alban,(unknown),Brent A. Bell,Paul R. Lockman,Babal K. Jha,Justin D. Lathia	29
8	Cancer Connectors: Connexins, Gap Junctions, and Communication 2018 ·Frontiers in Oncology ·Maksim Sinyuk,Erin E. Mulkearns-Hubert,Ofer Reizes,Justin D. Lathia	66
9	Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis 2018 ·JCI Insight ·Tyler Alban,Alvaro G. Alvarado,Mia Dahl Sørensen,Defne Bayık,(unknown),(unknown),Erin E. Mulkearns-Hubert,Maksim Sinyuk,James S. Hale,Giovana R. Onzi,Mary McGraw,Pengjing Huang,Matthew M. Grabowski,Connor Wathen,Manmeet S. Ahluwalia,Tomas Radivoyevitch,Harley I. Kornblum,Bjarne Winther Kristensen,Michael A. Vogelbaum,Justin D. Lathia	131
10	New Advances and Challenges of Targeting Cancer Stem Cells 2017 ·Cancer Research ·Nurmaa K. Dashzeveg,Rokana Taftaf,Erika K. Ramos,Luke A. Torre-Healy,(unknown),Daniel J. Silver,Tyler Alban,Maksim Sinyuk,Praveena Thiagarajan,Awad Jarrar,Soumya M. Turaga,Caner Saygin,Erin E. Mulkearns-Hubert,Masahiro Hitomi,Jeremy N. Rich,Stanton L. Gerson,Justin D. Lathia,Huiping Liu	16
11	STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance 2017 ·Endocrine Related Cancer ·Praveena Thiagarajan,Qiao Zheng,(unknown),Erin E. Mulkearns-Hubert,Martin G. Myers,Justin D. Lathia,Ofer Reizes	44
12	Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression 2017 ·Cell stem cell ·Alvaro G. Alvarado,Praveena Thiagarajan,Erin E. Mulkearns-Hubert,Daniel J. Silver,James S. Hale,Tyler Alban,Soumya M. Turaga,Awad Jarrar,Ofer Reizes,Michelle S. Longworth,Michael A. Vogelbaum,Justin D. Lathia	140
13	Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance 2015 ·Cancer Research ·Valery Adorno-Cruz,Golam Kibria,Xia Liu,Mary R. Doherty,Damian J. Junk,Dongyin Guan,(unknown),Monica Venere,Erin E. Mulkearns-Hubert,Maksim Sinyuk,Alvaro G. Alvarado,Arnold I. Caplan,Jeremy N. Rich,Stanton L. Gerson,Justin D. Lathia,Huiping Liu	200
14	Cancer stem cells in glioblastomabreakdown → 2015 ·Genes & Development ·Justin D. Lathia,Stephen C. Mack,Erin E. Mulkearns-Hubert,Claudia L.L. Valentim,Jeremy N. Rich	1182
15	Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling 2015 ·Neuro-Oncology ·Alvaro G. Alvarado,Soumya M. Turaga,Pratheesh Sathyan,Erin E. Mulkearns-Hubert,Balint Otvos,Daniel J. Silver,James S. Hale,William Flavahan,Pascal O. Zinn,Maksim Sinyuk,Meizhang Li,Maheedhara R. Guda,Kiran Kumar Velpula,Andrew J. Tsung,Ichiro Nakano,Michael A. Vogelbaum,Sadhan Majumder,Jeremy N. Rich,Justin D. Lathia	32
16	Cx25 contributes to leukemia cell communication and chemosensitivity 2015 ·Oncotarget ·Maksim Sinyuk,Alvaro G. Alvarado,(unknown),Jeremy J.P. Shaw,Erin E. Mulkearns-Hubert,(unknown),James S. Hale,Anna Bogdanova,Masahiro Hitomi,Jaroslaw P. Maciejewski,Alex Y. Huang,Yogen Saunthararajah,Justin D. Lathia	18
17	The clathrin adaptor Dab2 recruits EH domain scaffold proteins to regulate integrin β1 endocytosis 2012 ·Molecular Biology of the Cell ·Anjali Teckchandani,Erin E. Mulkearns-Hubert,Timothy W. Randolph,(unknown),Jonathan A. Cooper	48
18	FCH domain only-2 organizes clathrin-coated structures and interacts with Disabled-2 for low-density lipoprotein receptor endocytosis 2012 ·Molecular Biology of the Cell ·Erin E. Mulkearns-Hubert,Jonathan A. Cooper	36
19	Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo 2010 ·PLoS Genetics ·Vikram Khurana,Ilan Elson‐Schwab,Tudor A. Fulga,(unknown),Carin A. Loewen,Erin E. Mulkearns-Hubert,Jaana Tyynelä,Clemens R. Scherzer,Mel Β. Feany	124
20	S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila 2007 ·Journal of Neuroscience Research ·Michelle Leigh Steinhilb,Dora Dias‐Santagata,Erin E. Mulkearns-Hubert,Joshua M. Shulman,Jacek Biernat,Eva‐Maria Mandelkow,Mel Β. Feany	89

About Erin E. Mulkearns-Hubert

Erin E. Mulkearns-Hubert is a scholar working on Genetics, Cancer Research and Cell Biology, having authored 26 papers that have together received 2.3k indexed citations. Recurring topics across this work include Connexins and lens biology (8 papers), Cancer Cells and Metastasis (7 papers) and Glioma Diagnosis and Treatment (6 papers). The work is most often cited by research in Genetics (662 citations), Cancer Research (602 citations) and Oncology (729 citations). Erin E. Mulkearns-Hubert has collaborated with scholars based in United States, Denmark and Finland. Frequent co-authors include Justin D. Lathia, Jeremy N. Rich, Stephen C. Mack, Claudia L.L. Valentim, Ofer Reizes, Maksim Sinyuk, Alvaro G. Alvarado, James S. Hale, Jonathan A. Cooper and Mel Β. Feany. Their work appears in journals such as Genes & Development, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact